Lapatinib

CAS 231277-92-2 0 current records 1 historicalSmall Molecule

Who holds supplier records for Lapatinib? No organisation holds a current US Type II DMF or EU CEP for Lapatinib in the registers PharmaTek covers. A further 1 organisation has only historical (inactive) DMF filings.

Most records are filed under another form of this substance: Lapatinib Ditosylate (8 current sources). A DMF or CEP is listed under the form it names.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records

Cite as: PharmaTek, “Lapatinib: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/lapatinib

Reading the evidence

  • No current DMF or CEP on record

    Only historical filings exist in the covered registers. Any of these organisations may or may not supply today; confirm directly.

Current records (0)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Lapatinib. Country is the organisation's recorded country, not necessarily the manufacturing site.

Not found in the covered registers (FDA DMF list, EDQM). This is not evidence that no supplier exists.

Need Lapatinib sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Historical records (1)

Organisations whose Type II DMFs for Lapatinib are no longer active. These show a past filing, not current supply.

Show all 1 historical record
  • Sichuan Xieli Pharmaceutical Co Ltd
    China · Inactive DMF 26465 · filed Sept 2012

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Lapatinib is a small molecule tyrosine kinase inhibitor used in the treatment of HER2-positive breast cancer. It works by inhibiting the epidermal growth factor receptor (EGFR) and HER2/neu receptor pathways, which are involved in tumor cell proliferation.

Chemical identity

IUPAC name
N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]quinazolin-4-amine
Canonical SMILES
CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl
InChIKey
BCFGMOOMADDAQU-UHFFFAOYSA-N
Synonyms
Tykerb API, gsk-572016, gw-572016, gw-572016x, gw572016

Therapeutic areas

OncologyBreast CancerHER2-positive Breast Cancer

Record history

PharmaTek records which organisations hold a current DMF or CEP for Lapatinib every week, starting 23 Oct 2026. Additions and lapses will appear here from the next weekly release.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

What do the historical Lapatinib records mean?

1 organisation has only inactive Type II DMFs for Lapatinib. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

How do I qualify a Lapatinib supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Lapatinib?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.